Table 1.
Transmission and viral containment in HIV infected and exposed uninfected infants by TLR9 allele polymorphism.
| HIV+ infants | HEU infants | |||||
|---|---|---|---|---|---|---|
| TLR9 GA or AA | TLR9 GG | p value | TLR9 GA or AA | TLR9 GG | p value | |
| CMV infection and containment | ||||||
| Ever CMV infected a | 100% (19/19) | 89% (16/18) | 0.1 | 100% (10/10) | 89% (8/9) | 0.3 |
| CMV infected by 1 month a | 42% (8/19) | 11% (2/18) | 0.03 | 20% (2/10) | 22% (2/9) | 0.9 |
| Median log10 CMV DNA copies/ml (IQR)b | 2.4 (2.1–3.1) | 2.9 (2.1–3.1) | 0.9 | 2.5 (1.7–3.3) | 2.3 (2.1–2.4) | 0.8 |
| EBV infection and containment | ||||||
| Ever EBV infected a | 69% (24/35) | 78% (21/27) | 0.4 | 57% (13/23) | 16% (3/19) | 0.007 |
| Probability of EBV infection at 12 months [95%CI]c | 0.82 [0.64–0.94] | 0.67 [0.47–0.85] | 0.2 | 0.67 [0.46–0.86] | 0.21 [0.075–0.53] | 0.003 |
| Median log10 EBV DNA copies/ml (IQR)b | 2.4 (2.0–2.6) | 2.8 (2.4–2.9) | 0.02 | 2.1 (1.8–2.5) | 1.9 d | * |
Notes.
Chi-square test,
Mann-Whitney U test,
z test comparing infection probabilities at 12 months from Kaplan-Meier model.
Only 1 HEU infant was EBV viremic in the GG group, so comparison was not possible.